Clinical observations suggest that isolated clinical manifestations may also occur in carriers of heterozygous mutations in the ALMS1 and BBS genes, i.e., in parents and siblings of patients with ALMS and BBS [2,16,17,18,19,20]. This evidence concerns the gene ALMS1 and Bardet-Biedl syndrome.